Dr. Lu Xianping was invited to attend the 2016 International Forum on Immunization and Disease Research and the 70th Anniversary of Jilin University in Changchun

August 16,2016

From August 6 to 7, 2016, the 2016 International Forum on Immunization and Disease Research and the 70th Anniversary of Jilin University in Changchun were successfully held at the multifunctional hall of the First Hospital of Jilin University. Under the theme of " Immune Treatment and Scientific Research Transformation of Diseases", the meeting discussed in depth the frontier issues of basic research and scientific research transformation of immune treatment of diseases, aiming at establishing a platform for exchange and cooperation at home and abroad in the field of basic medicine and transformation research and discussing the major issues and future directions of innovation and development in this field.

Dr. Lu Xianping, the president of CHIPSCREEN BIOSCIENCES, was invited to attend the meeting and gave an excellent report on epigenetic immune mechanism and tumor treatment. He shared and summarized his research and development experience with the participants with warm atmosphere.

It is reported that 23 well-known experts at home and abroad made presentations for the meeting, including the discoverer of TCR, the academician of the Canadian Royal Academy, the academician of the British Royal Academy, the  Professor Tak Mak who is the overseas academician of the American Academy of Sciences, the discoverer of PD - L1, Professor Chen Lieping from Yale University, Professor He Wei from the Chinese Academy of Medical Sciences, Professor Tian Zhigang from the Chinese University of Science and Technology, etc.. The conference attracted more than 400 scientific research colleagues from the Department of Medicine of Peking University, Xinjiang Medical University, 302 Hospital of the People's Liberation Army, the First Hospital of Jilin University, and the School of Life Sciences to share this feast of scientific research and academic exchange.

More Press Releases